Sunshine Biopharma Inc.

SBFMNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
2.46 USD
↘ 0.11 (4.28%)AT CLOSE (11:59 AM EDT)
2.47
↗ 0.01 (0.37%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
2.47
↗ 0.01 (0.37%)
🔴Market: CLOSED
Open?$2.47
High?$2.54
Low?$2.45
Prev. Close?$2.57
Volume?283.0K
Avg. Volume?28.0M
VWAP?$2.50
Rel. Volume?0.01x
Bid / Ask
Bid?$2.44 × 200
Ask?$2.50 × 800
Spread?$0.06
Midpoint?$2.47
Valuation & Ratios
Market Cap?4.0M
Shares Out?2.1M
Float?4.9M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?0.18
EPS?-$3.74
Dividend?0.00%
Ex-Dividend?N/A

Sunshine Biopharma Inc. (SBFM) trades at $2.46 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Infectious Disease & Vaccines
Employees
50
Market Cap
4.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.sunshinebiopharma.com
Listed
2007-08-09
Address
333 LAS OLAS WAY
FORT LAUDERDALE, FL 33301
Phone: 954-330-0684
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
36
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.11Distress
Confidence?52%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.12%High
Short Interest?496.1K
Days to Cover?1.5
Free Float4.9M
Avg Daily Volume321.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?4.22Strong
Quick Ratio?1.98Adequate
Cash Ratio?1.18Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.18CHEAP▾
P/S?
Peers
100
S&P
97
0.11CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.8CHEAP▾
EV/Sales?
S&P
97
-0.08CHEAP▾
Returns & Efficiency
ROE?
S&P
6
-28.1%WEAK▾
ROA?
S&P
3
-21.6%WEAK▾
Cash Flow & Enterprise
FCF?$-5861468
Enterprise Value?$-2936192
Fundamentals ratios updated end of day
MarketsMoversWatchlist